ANTIPHOSPHOLIPID ANTIBODY (aPL) PRESENCE IN COVID-19 PATIENTS

---

Neijmann S. T., Kural A., Isiksacan N., Karabela S. N., Ordekci S., Gunver M. G., ...More

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, vol.85, no.3, pp.285-290, 2022 (ESCI)

• Publication Type: Article / Article
• Volume: 85 Issue: 3
• Publication Date: 2022
• Doi Number: 10.26650/iuitfd.1059659
• Journal Name: JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
• Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Page Numbers: pp.285-290
• Keywords: COVID-19, thromboembolism, antiphospholipid antibody
• Open Archive Collection: AVESIS Open Access Collection
• Istanbul University Affiliated: Yes

Abstract

Objective: In our study, we aimed to show whether there is a relationship between antiphospholipid antibody (aPL) positivity and complications of COVID-19.